Wex Pharmaceuticals posts wider Q2 loss on higher research expenses

VANCOUVER (CP) - Wex Pharmaceuticals, a developer of new analgesic treatments to relieve pain, lost more money in its second quarter as research costs climbed due to expanded clinical trial activities. Wex said it lost $2....More